Literature DB >> 10364368

Retroviral vectors pseudotyped with lymphocytic choriomeningitis virus.

H Miletic1, M Bruns, K Tsiakas, B Vogt, R Rezai, C Baum, K Kühlke, F L Cosset, W Ostertag, H Lother, D von Laer.   

Abstract

Pseudotyping can improve retroviral vector stability and transduction efficiency. Here, we describe a novel pseudotype of murine leukemia virus packaged with lymphocytic choriomeningitis virus (LCMV). This pseudotype was stable during ultracentrifugation and infected several cell lines from different species. Moreover, LCMV glycoproteins were not cell toxic.

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10364368      PMCID： PMC112677     

Source DB:  PubMed          Journal:  J Virol        ISSN： 0022-538X            Impact factor:   5.103


  28 in total

Review 1.  Pseudotyped retroviral vectors for studies of human gene therapy.

Authors:  T Friedmann; J K Yee
Journal:  Nat Med       Date:  1995-03       Impact factor: 53.440

2.  High-titer packaging cells producing recombinant retroviruses resistant to human serum.

Authors:  F L Cosset; Y Takeuchi; J L Battini; R A Weiss; M K Collins
Journal:  J Virol       Date:  1995-12       Impact factor: 5.103

3.  Characterization of lymphocytic choriomeningitis virus-binding protein(s): a candidate cellular receptor for the virus.

Authors:  P Borrow; M B Oldstone
Journal:  J Virol       Date:  1992-12       Impact factor: 5.103

4.  Molecular determinants of macrophage tropism and viral persistence: importance of single amino acid changes in the polymerase and glycoprotein of lymphocytic choriomeningitis virus.

Authors:  M Matloubian; S R Kolhekar; T Somasundaram; R Ahmed
Journal:  J Virol       Date:  1993-12       Impact factor: 5.103

5.  Growth factors increase amphotropic retrovirus binding to human CD34+ bone marrow progenitor cells.

Authors:  G M Crooks; D B Kohn
Journal:  Blood       Date:  1993-12-01       Impact factor: 22.113

6.  Downregulation of c-kit (stem cell factor receptor) in transformed hematopoietic precursor cells by stroma cells.

Authors:  C Heberlein; J Friel; C Laker; D von Laer; U Bergholz; M Bögel; L K Ashman; K Klingler; W Ostertag
Journal:  Blood       Date:  1999-01-15       Impact factor: 22.113

7.  Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells.

Authors:  J C Burns; T Friedmann; W Driever; M Burrascano; J K Yee
Journal:  Proc Natl Acad Sci U S A       Date:  1993-09-01       Impact factor: 11.205

8.  Inducible, high-level production of infectious murine leukemia retroviral vector particles pseudotyped with vesicular stomatitis virus G envelope protein.

Authors:  Y Yang; E F Vanin; M A Whitt; M Fornerod; R Zwart; R D Schneiderman; G Grosveld; A W Nienhuis
Journal:  Hum Gene Ther       Date:  1995-09       Impact factor: 5.695

9.  Retroviral vectors related to the myeloproliferative sarcoma virus allow efficient expression in hematopoietic stem and precursor cell lines, but retroviral infection is reduced in more primitive cells.

Authors:  G Beck-Engeser; C Stocking; U Just; L Albritton; M Dexter; E Spooncer; W Ostertag
Journal:  Hum Gene Ther       Date:  1991       Impact factor: 5.695

10.  Virus-induced immunosuppression: immune system-mediated destruction of virus-infected dendritic cells results in generalized immune suppression.

Authors:  P Borrow; C F Evans; M B Oldstone
Journal:  J Virol       Date:  1995-02       Impact factor: 5.103
View more
  16 in total

1.  Recombinant expression of lymphocytic choriomeningitis virus strain WE glycoproteins: a single amino acid makes the difference.

Authors:  W R Beyer; H Miletic; W Ostertag; D von Laer
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

2.  Transduction efficiency of MLV but not of HIV-1 vectors is pseudotype dependent on human primary T lymphocytes.

Authors:  Michael D Mühlebach; Isabel Schmitt; Stefanie Steidl; Jörn Stitz; Matthias Schweizer; Thomas Blankenstein; Klaus Cichutek; Wolfgang Uckert
Journal:  J Mol Med (Berl)       Date:  2003-10-24       Impact factor: 4.599

3.  An envelope glycoprotein of the human endogenous retrovirus HERV-W is expressed in the human placenta and fuses cells expressing the type D mammalian retrovirus receptor.

Authors:  J L Blond; D Lavillette; V Cheynet; O Bouton; G Oriol; S Chapel-Fernandes; B Mandrand; F Mallet; F L Cosset
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

Review 4.  Altering the tropism of lentiviral vectors through pseudotyping.

Authors:  James Cronin; Xian-Yang Zhang; Jakob Reiser
Journal:  Curr Gene Ther       Date:  2005-08       Impact factor: 4.391

Review 5.  Viral vectors: from virology to transgene expression.

Authors:  D Bouard; D Alazard-Dany; F-L Cosset
Journal:  Br J Pharmacol       Date:  2009-05       Impact factor: 8.739

6.  Properties of wild-type, C-terminally truncated, and chimeric maedi-visna virus glycoprotein and putative pseudotyping of retroviral vector particles.

Authors:  U Zeilfelder; V Bosch
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

7.  Retroviral vectors pseudotyped with severe acute respiratory syndrome coronavirus S protein.

Authors:  Tsanan Giroglou; Jindrich Cinatl; Holger Rabenau; Christian Drosten; Harald Schwalbe; Hans Wilhelm Doerr; Dorothee von Laer
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

8.  In vivo gene transfer using a nonprimate lentiviral vector pseudotyped with Ross River Virus glycoproteins.

Authors:  Yubin Kang; Colleen S Stein; Jason A Heth; Patrick L Sinn; Andrea K Penisten; Patrick D Staber; Kenneth L Ratliff; Hong Shen; Carrie K Barker; Inês Martins; C Matthew Sharkey; David Avram Sanders; Paul B McCray; Beverly L Davidson
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

9.  Remission of invasive, cancer stem-like glioblastoma xenografts using lentiviral vector-mediated suicide gene therapy.

Authors:  Peter C Huszthy; Tsanan Giroglou; Oleg Tsinkalovsky; Philipp Euskirchen; Kai Ove Skaftnesmo; Rolf Bjerkvig; Dorothee von Laer; Hrvoje Miletic
Journal:  PLoS One       Date:  2009-07-20       Impact factor: 3.240

10.  Using viral vectors as gene transfer tools (Cell Biology and Toxicology Special Issue: ETCS-UK 1 day meeting on genetic manipulation of cells).

Authors:  Joanna L Howarth; Youn Bok Lee; James B Uney
Journal:  Cell Biol Toxicol       Date:  2009-10-15       Impact factor: 6.691
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.